Nyxoah partnering with ResMed in Germany

Nyxoah has entered into a partnership with ResMed Germany to increase OSA awareness and therapy penetration in the German market. Nyxoah and ResMed Germany will establish a continuum of care that will educate and guide OSA patients in the German market from diagnosis through treatment. Together, the companies will work to accelerate patient identification and better support patient set-up on the appropriate therapy. The companies will collaborate on OSA helplines and direct-to-consumer marketing initiatives, sales and marketing efforts targeting ENTs and sleep physicians and patient and clinician educational programs and symposiums.